CAM
SGMO

ClariVest Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

ClariVest Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50,202
Closed -$377K – 778
2021
Q4 		$377K Sell
50,202
-2,991
-6% -$26K 0.01% 454
2021
Q3 		$479K Sell
53,193
-2,252
-4% -$22.3K 0.02% 443
2021
Q2 		$663K Buy
55,445
+124
+0.2% +$1.4K 0.02% 388
2021
Q1 		$693K Sell
55,321
-3,300
-6% -$44.5K 0.02% 352
2020
Q4 		$915K Sell
58,621
-80,061
-58% -$938K 0.03% 284
2020
Q3 		$1.31M Sell
138,682
-6,224
-4% -$67.3K 0.04% 275
2020
Q2 		$1.3M Sell
144,906
-3,596
-2% -$33.4K 0.04% 287
2020
Q1 		$946K Buy
148,502
+323
+0.2% +$2.4K 0.03% 306
2019
Q4 		$1.24M Sell
148,179
-99,897
-40% -$919K 0.03% 324
2019
Q3 		$2.25M Sell
248,076
-3,100
-1% -$34.8K 0.05% 246
2019
Q2 		$2.71M Buy
251,176
+140,450
+127% +$1.49M 0.06% 220
2019
Q1 		$1.06M Sell
110,726
-8,108
-7% -$82.8K 0.02% 392
2018
Q4 		$1.36M Buy
118,834
+2,586
+2% +$32.1K 0.03% 356
2018
Q3 		$1.97M Sell
116,248
-2,051
-2% -$31.2K 0.03% 326
2018
Q2 		$1.68M Sell
118,299
-9,722
-8% -$161K 0.03% 367
2018
Q1 		$2.43M Buy
128,021
+500
+0.4% +$10.7K 0.04% 313
2017
Q4 		$2.09M Buy
+127,521
New +$1.9M 0.04% 337

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ClariVest Asset Management's SGMO Position: Q1 2022 in Review

ClariVest Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2022, closing a stake of 50,202 shares — an estimated $377K sold.

ClariVest Asset Management first reported a position in SGMO in Q4 2017 and held it in 17 quarters. The position peaked at $2.71M in Q2 2019. 195 funds tracked by Wall St. Rank hold SGMO as of Q1 2022.

  • ClariVest Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2022 after selling out during the quarter.
  • ClariVest Asset Management sold 50,202 SANGAMO THERAPEUTICS INC shares in Q1 2022, an estimated $377K.
  • ClariVest Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2017 and held it in 17 quarters.
  • ClariVest Asset Management's SANGAMO THERAPEUTICS INC position peaked at $2.71M in Q2 2019.
  • 195 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2022.

Based on ClariVest Asset Management's 13F filing for Q1 2022, filed 4 May 2022.